Which HIV prevention shot do patients prefer? new study aims to find out
NCT ID NCT07379658
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will survey 128 adults in Louisville, Kentucky who are already taking or starting a long-acting injectable HIV PrEP shot. Participants will answer questionnaires about their satisfaction and adherence to either lenacapavir or cabotegravir over 12 months. The goal is to understand real-world preferences and outcomes, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors and patients choose the long-acting injectable PrEP that works best for them, improving HIV prevention.
What could go wrong
This is an observational study, not a treatment trial. It only measures satisfaction and adherence, not whether the drugs prevent HIV better than other options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV PRE-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Norton Healthcare
Louisville, Kentucky, 40202, United States
Contact
-
University of Louisville, Kent School of Social Work
Louisville, Kentucky, 40292, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Louisville, School of Public Health and Information Sciences
Louisville, Kentucky, 40202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact